Guggenheim Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q3
– Sell
-20,000
Closed -$1.52M – 3078
2013
Q2
$1.52M Buy
+20,000
New +$1.31M 0.01% 1711

Other funds holding CME

Guggenheim Capital's CME Position: Q2 2026 in Review

Guggenheim Capital increased its CME Group (CME) stake by 33% in Q2 2026, buying an estimated $1.16M and bringing the position to 16,984 shares worth $3.75M. The position accounts for 0.02% of the portfolio, ranked #531.

Guggenheim Capital first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $52.4M in Q4 2021. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Guggenheim Capital held 16,984 shares of CME Group worth $3.75M as of Q2 2026.
  • Guggenheim Capital bought 4,193 CME Group shares in Q2 2026, an estimated $1.16M.
  • CME Group made up 0.02% of Guggenheim Capital's portfolio in Q2 2026, its #531 holding.
  • Guggenheim Capital first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Guggenheim Capital's CME Group position peaked at $52.4M in Q4 2021.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.